发明名称 |
Amnion-derived cell compositions, methods of making and uses thereof |
摘要 |
The invention is directed to substantially purified amnion-derived cell populations, compositions comprising the substantially purified amnion-derived cell populations, and to methods of creating such substantially purified amnion-derived cell populations, as well as methods of use. The invention is further directed to antibodies, in particular, monoclonal antibodies, that bind to amnion-derived cells or, alternatively, to one or more amnion-derived cell surface protein markers. The invention is further directed to methods for producing the antibodies, methods for using the antibodies, and kits comprising the antibodies. |
申请公布号 |
US8741646(B2) |
申请公布日期 |
2014.06.03 |
申请号 |
US201113317001 |
申请日期 |
2011.10.06 |
申请人 |
Stemnion, Inc. |
发明人 |
Emig Charlotte A;Marshall Vivienne S |
分类号 |
C12N5/00 |
主分类号 |
C12N5/00 |
代理机构 |
|
代理人 |
|
主权项 |
1. A composition comprising conditioned media, wherein the conditioned media is made by a method comprising the steps of
a) obtaining a placenta and isolating an amnion from the placenta, b) enzymatically releasing amnion-derived epithelial cells from the amnion, c) collecting the released amnion-derived epithelial cells, d) culturing the collected amnion-derived epithelial cells of step (c) in basal culture medium that is supplemented with human serum albumin and recombinant human EGF; e) removing the culture medium after about 2-3 days and applying fresh culture medium; and f) collecting the culture medium after culturing the cells for 2-3 days.
|
地址 |
Pittsburgh PA US |